Shorts and Buyback:The float on Viemed is about 34 million shares.
The short position on June 15th was 1.71 million shares.
I don't think they bought all there shares back yet, which adds to the short position. Volume has gone up big creating a new base.
The company gave guidance for about 32.5 million core revenue for the second quarter.
They hired 25 more people in a month.
The bottom line is I wouldn't want to be short, or chasing the stock.
They said they have all the equipment they need at this time, and are back to normal on the June call.
-----------------------------------------------------------------------------------------------------
To be fair, I wish they would put out more releases. And they are very cocky managers, but they get the job done. The money they made during Covid enabled them to buy two other buildings for cash, and more vents.